Erik Rasbach
Papers
5
Total Citations
88
H-Index
5
About
Erik Rasbach is a pioneering hepatobiliary and minimally invasive surgeon whose research is reshaping the landscape of liver surgery. His primary focus lies in advancing robotic and laparoscopic techniques for complex hepatic resections, particularly for malignancies and centrally located lesions. Rasbach’s most impactful contribution is the landmark ROC’N’ROLL trial (36 citations), the first single-centre, randomised, controlled trial comparing robotic versus laparoscopic hepatectomy for liver malignancies, providing crucial evidence on quality-of-life outcomes. He has also demonstrated the feasibility and safety of minimally invasive mesohepatectomy for central liver lesions (22 citations) and shown that robotic or laparoscopic repeat hepatectomy after open surgery is a viable option (19 citations). His work on reducing central venous pressure during minimally invasive liver resection (6 citations) addresses a key technical challenge to improve perioperative outcomes. Beyond liver surgery, Rasbach has contributed to emergency surgical innovation, as seen in his successful two-stage minimally invasive treatment for gastric necrosis after caustic ingestion (5 citations). With a growing citation record and a focus on high-quality clinical trials, Rasbach is establishing himself as a leading voice in the evidence-based adoption of robotic surgery for complex hepatobiliary disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5